Exchange: NASDAQ·Updated 03:59 PM EDT

CERO CERo Therapeutics Holdings Inc

$0.0106
$0.0052
(32.91%)
Today
Mkt Cap$1.13M
Vol1.71M

About CERO

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.
84

Extremely Bullish Sentiment

How do you feel about CERO?

Advertisement|Remove ads.